Learn More
Medchemexpress LLC Sparfosic acid | 51321-79-0 | 99.3% | 255.12 | 10 MG

Supplier: Medchemexpress LLC HY11273210MG
Sparfosic acid, a DNA antimetabolite agent, is a potent inhibitor of aspartate transcarbamoyl transferase, the enzyme catalyzing the second step of de novo pyrimidine biosynthesis. Sparfosic acid synergistically enhances the cytotoxicity of a combination of 5-fluorouracil (5-FU) and interferon-alpha (IFN) against human colon cancer cell lines.
- Causes apoptosis in resistant Br1 cells.
- Leads to progressive accumulation of cells in S phase and activation of an apoptotic pathway at 300 μM.
- Increased life-span by 77% to 86% in mice bearing B16 melanoma.
- Lewis lung carcinoma is highly sensitive to Sparfosic acid.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.